Background: The minimal dose for oral immunotherapy (OIT) tolerance is unknown. We investigated the efficacy and safety of low-dose OIT with 1/32 of the volume of a whole egg. Methods: Thirty-three children (aged ≥5 years) with egg allergies confirmed by oral food challenge against 1/32 of a heated whole egg (194 mg of egg protein) were enrolled. The OIT group ingested a scrambled egg once a day. The volume was gradually increased up to a maximum of 1/32 of a heated whole egg. Egg consumption was completely absent in the control group. Results: There were no significant differences in background between the OIT and control groups. Respectively, 71% (15/21) and 0% (0/12) of the patients in the OIT and control groups exhibited sustained unresponsiveness to 1/32 of a whole egg 2 weeks after stopping OIT after 12 months (p < 0.001); 33% (7/21) and 0% (0/12; p = 0.032), respectively, showed sustained unresponsiveness to 1/2 of a whole egg. Egg white- or ovomucoid-specific IgE levels in the OIT group were significantly lower than at baseline after 12 months. Egg white- or ovomucoid-specific IgG as well as IgG4 levels in the OIT group were significantly higher than baseline levels after 1, 3, 6, and 12 months. Adverse allergic reactions were rare, and most symptoms were mild. Conclusions: Low-dose OIT induced sustained unresponsiveness to 1/32 and 1/2 of a whole egg, with no severe symptoms. To improve food allergies, continuous intake of small amounts of these foods may be as effective as the consumption of larger quantities.

1.
Urisu A, Ebisawa M, Ito K, Aihara Y, Ito S, Mayumi M, Kohno Y, Kondo N: Japanese guideline for food allergy 2014. Allergol Int 2014;63:399-419.
2.
Burks AW, Tang M, Sicherer S, Muraro A, Eigenmann PA, Ebisawa M, Fiocchi A, Chiang W, Beyer K, Wood R, Hourihane J, Jones SM, Lack G, Sampson HA: ICON: food allergy. J Allergy Clin Immunol 2012;129:906-920.
3.
Hasan SA, Wells RD, Davis CM: Egg hypersensitivity in review. Allergy Asthma Proc 2013;34:26-32.
4.
Burks AW, Jones SM, Wood RA, Fleischer DM, Sicherer SH, Lindblad RW, Stablein D, Henning AK, Vickery BP, Liu AH, Scurlock AM, Shreffler WG, Plaut M, Sampson HA; Consortium of Food Allergy Research (CoFAR): Oral immunotherapy for treatment of egg allergy in children. N Engl J Med 2012;367:233-243.
5.
Caminiti L, Pajno GB, Crisafulli G, Chiera F, Collura M, Panasci G, Ruggeri P, Guglielmo F, Passalacqua G: Oral immunotherapy for egg allergy: a double-blind placebo-controlled study, with postdesensitization follow-up. J Allergy Clin Immunol Pract 2015;3:532-539.
6.
Vazquez-Ortiz M, Turner PJ: Improving the safety of oral immunotherapy for food allergy. Pediatr Allergy Immunol 2016;27:117-125.
7.
Meglio P, Giampietro PG, Carello R, Gabriele I, Avitabile S, Galli E: A new protocol with raw hen's egg. Pediatr Allergy Immunol 2013;24:75-83.
8.
Bravin K, Luyt D: Home-based oral immunotherapy with a baked egg protocol. J Investig Allergol Clin Immunol 2016;26:61-63.
9.
Yanagida N, Okada Y, Sato S, Ebisawa M: New approach for food allergy management using low-dose oral food challenges and low-dose oral immunotherapies. Allergol Int 2016;65:135-140.
10.
Yanagida N, Sato S, Asaumi T, Okada Y, Ogura K, Ebisawa M: A single-center, case-control study of low-dose-induction oral immunotherapy with cow's milk. Int Arch Allergy Immunol 2015;168:131-137.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.